ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,527 | +10.3% | 429 | +46.4% | 0.00% | 0.0% |
| Q2 2023 | $10,448 | +112.0% | 293 | +51.0% | 0.00% | 0.0% |
| Q1 2023 | $4,928 | -81.8% | 194 | -71.0% | 0.00% | -66.7% |
| Q4 2022 | $27,094 | +12.9% | 668 | -8.0% | 0.00% | -25.0% |
| Q3 2022 | $24,000 | -4.0% | 726 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $25,000 | -24.2% | 719 | +0.1% | 0.00% | -20.0% |
| Q1 2022 | $33,000 | -56.6% | 718 | -37.2% | 0.01% | -58.3% |
| Q4 2021 | $76,000 | +7500.0% | 1,144 | +10300.0% | 0.01% | – |
| Q3 2021 | $1,000 | -92.9% | 11 | -94.8% | 0.00% | -100.0% |
| Q1 2021 | $14,000 | -67.4% | 213 | -78.7% | 0.00% | -75.0% |
| Q3 2020 | $43,000 | – | 1,000 | – | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $33,000 | -21.4% | 515 | -65.7% | 0.01% | -31.2% |
| Q3 2019 | $42,000 | +7.7% | 1,500 | 0.0% | 0.02% | +6.7% |
| Q2 2019 | $39,000 | -46.6% | 1,500 | -62.5% | 0.02% | -48.3% |
| Q1 2019 | $73,000 | +40.4% | 4,000 | -4.8% | 0.03% | +11.5% |
| Q4 2018 | $52,000 | – | 4,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |